Works matching Lung diseases

Results: 5000
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Management of Interstitial Lung Diseases: A consensus statement of the Indian Chest Society (ICS) and National College of Chest Physicians (NCCP).

    Published in:
    Lung India, 2020, v. 37, n. 4, p. 359, doi. 10.4103/lungindia.lungindia_275_20
    By:
    • Singh, Sheetu;
    • Sharma, Bharat Bhushan;
    • Bairwa, Mohan;
    • Gothi, Dipti;
    • Desai, Unnati;
    • Joshi, Jyotsna M.;
    • Talwar, Deepak;
    • Singh, Abhijeet;
    • Dhar, Raja;
    • Sharma, Ambika;
    • Ahluwalia, Bineet;
    • Mangal, Daya K.;
    • Jain, Nirmal K.;
    • Pilania, Khushboo;
    • Hadda, Vijay;
    • Koul, Parvaiz A.;
    • Luhadia, Shanti Kumar;
    • Swarnkar, Rajesh;
    • Gaur, Shailender Nath;
    • Ghoshal, Aloke G.
    Publication type:
    Article
    16
    17

    First Genotype--Phenotype Study in TBX4 Syndrome: Gain-of-Function Mutations Causative for Lung Disease.

    Published in:
    American Journal of Respiratory & Critical Care Medicine, 2022, v. 206, n. 12, p. 1522, doi. 10.1164/rccm.202203-0485OC
    By:
    • Prapa, Matina;
    • Lago-Docampo, Mauro;
    • Swietlik, Emilia M.;
    • Montani, David;
    • Eyries, Mélanie;
    • Humbert, Marc;
    • Welch, Carrie L.;
    • Chung, Wendy K.;
    • Berger, Rolf M. F.;
    • Bogaard, Harm Jan;
    • Danhaive, Olivier;
    • Escribano-Subías, Pilar;
    • Gall, Henning;
    • Girerd, Barbara;
    • Hernandez-Gonzalez, Ignacio;
    • Holden, Simon;
    • Hunt, David;
    • Jansen, Samara M. A.;
    • Kerstjens-Frederikse, Wilhelmina;
    • Kiely, David G.
    Publication type:
    Article
    18
    19
    20
    21
    22

    Proteases, Mucus, and Mucosal Immunity in Chronic Lung Disease.

    Published in:
    International Journal of Molecular Sciences, 2021, v. 22, n. 9, p. 5018, doi. 10.3390/ijms22095018
    By:
    • McKelvey, Michael C.;
    • Brown, Ryan;
    • Ryan, Sinéad;
    • Mall, Marcus A.;
    • Weldon, Sinéad;
    • Taggart, Clifford C.;
    • Martin, Lorraine;
    • Roth, Michael
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi‐center US‐based longitudinal registry.

    Published in:
    International Journal of Rheumatic Diseases, 2022, v. 25, n. 2, p. 163, doi. 10.1111/1756-185X.14253
    By:
    • Castelino, Flavia V.;
    • VanBuren, John M.;
    • Startup, Emily;
    • Assassi, Shervin;
    • Bernstein, Elana J.;
    • Chung, Lorinda;
    • Correia, Chase;
    • Evnin, Luke B.;
    • Frech, Tracy M.;
    • Gordon, Jessica K.;
    • Hant, Faye N.;
    • Hummers, Laura K.;
    • Khanna, Dinesh;
    • Sandorfi, Nora;
    • Shah, Ami A.;
    • Shanmugam, Victoria K.;
    • Steen, Virginia
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39

    Secreted Phosphoprotein 1 in Lung Diseases.

    Published in:
    Metabolites (2218-1989), 2025, v. 15, n. 6, p. 365, doi. 10.3390/metabo15060365
    By:
    • Liu, Hongli;
    • Coarfa, Cristian;
    • Charania, Arzoo N.;
    • Larson-Casey, Jennifer L.;
    • Rosas, Ivan O.;
    • He, Chao
    Publication type:
    Article
    40
    41

    OR2AT4 and OR1A2 counterregulate molecular pathophysiological processes of steroid-resistant inflammatory lung diseases in human alveolar macrophages.

    Published in:
    Molecular Medicine, 2022, v. 28, n. 1, p. 1, doi. 10.1186/s10020-022-00572-8
    By:
    • Weidinger, Daniel;
    • Jamal Jameel, Kaschin;
    • Alisch, Desiree;
    • Jacobsen, Julian;
    • Bürger, Paul;
    • Ruhe, Matthias;
    • Yusuf, Faisal;
    • Rohde, Simon;
    • Störtkuhl, Klemens;
    • Kaufmann, Peter;
    • Kronsbein, Juliane;
    • Peters, Marcus;
    • Hatt, Hanns;
    • Giannakis, Nikolaos;
    • Knobloch, Jürgen
    Publication type:
    Article
    42
    43
    44
    45
    46

    Non-anti-TNF biologic agents are associated with slower worsening of interstitial lung disease secondary to rheumatoid arthritis.

    Published in:
    Clinical Rheumatology, 2021, v. 40, n. 1, p. 133, doi. 10.1007/s10067-020-05227-9
    By:
    • Mena-Vázquez, Natalia;
    • Godoy-Navarrete, Francisco Javier;
    • Manrique-Arija, Sara;
    • Aguilar-Hurtado, María Carmen;
    • Romero-Barco, Carmen María;
    • Ureña-Garnica, Inmaculada;
    • Espildora, F;
    • Añón-Oñate, Isabel;
    • Pérez-Albaladejo, Lorena;
    • Gomez-Cano, Carmen;
    • Jimenez-Núñez, Francisco Gabriel;
    • Padin-Martín, María Isabel;
    • Fernández-Nebro, Antonio
    Publication type:
    Article
    47
    48
    49

    Assessment of interstitial lung disease among black rheumatoid arthritis patients.

    Published in:
    Clinical Rheumatology, 2019, v. 38, n. 12, p. 3413, doi. 10.1007/s10067-019-04760-6
    By:
    • McFarlane, Isabel M.;
    • Zhaz, Su Yien;
    • Bhamra, Manjeet S.;
    • Burza, Aaliya;
    • Kolla, Srinivas;
    • Alvarez, Milena Rodriguez;
    • Koci, Kristaq;
    • Taklalsingh, Nicholas;
    • Pathiparampil, Joshy;
    • Freeman, Latoya;
    • Kaplan, Ian;
    • Kabani, Naureen;
    • Ozeri, David J.;
    • Watler, Elsie;
    • Frefer, Mosab;
    • Vaitkus, Vytas;
    • Matthew, Keron;
    • Arroyo-Mercado, Fray;
    • Lyo, Helen;
    • Zrodlowski, Tomasz
    Publication type:
    Article
    50